PDT Partners’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Other funds holding VYGR
AC
EC
FCM
VPC
EAM
PDT Partners's VYGR Position: Q4 2024 in Review
PDT Partners sold out of Voyager Therapeutics (VYGR) in Q4 2024, closing a stake of 22,163 shares — an estimated $130K sold.
PDT Partners first reported a position in VYGR in Q3 2017 and held it in 16 quarters. The position peaked at $2.9M in Q4 2017. 132 funds tracked by Wall St. Rank hold VYGR as of Q4 2024.
- PDT Partners reported no remaining Voyager Therapeutics position as of Q4 2024 after selling out during the quarter.
- PDT Partners sold 22,163 Voyager Therapeutics shares in Q4 2024, an estimated $130K.
- PDT Partners first reported a position in Voyager Therapeutics in Q3 2017 and held it in 16 quarters.
- PDT Partners's Voyager Therapeutics position peaked at $2.9M in Q4 2017.
- 132 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2024.
Based on PDT Partners's 13F filing for Q4 2024, filed 14 Feb 2025.